Demand for PSA's services has grown exponentially over the last six years, prompting significant increases to its operations. Bruce Bennett / Getty Images Professional Sports Authenticator’s parent ...

Planning on sending any of your all-new 2026 Bowman cards into PSA for grading? Get ready to wait. Because you might not get them back until 2027. In an email to PSA members on Thursday with the ...

Higher fees and longer wait times are discouraging submissions while driving scarcity premiums for high-grade PSA 10 cards. The PSA grading policy changes in April 2026 are now fully impacting the ...

The federal government’s reclassification of medical marijuana products as Schedule III drugs doesn’t federally legalize marijuana, but it might extend tax breaks to some cannabis businesses.

Markets ebb and flow. The stock market, the crypto market, and the card market. But you can't take these in small sample sizes. You need to look at the broader picture to get a real feel of how ...

Washington — The Justice Department announced Thursday that it has issued an order rescheduling certain marijuana products to a lower drug classification, while moving to expedite the process to ...

(NEXSTAR) – As was roughly anticipated, the Trump administration has moved to partially reclassify marijuana, announcing on Thursday that state-licensed medical marijuana will now be considered a less ...

Acting Attorney General Todd Blanche signed an order Thursday to reclassify state-licensed medical marijuana as a less dangerous drug. The order shifts the designation of licensed medical marijuana ...

The rule moves F.D.A.-approved marijuana and state-regulated marijuana out of the Schedule I category, which includes drugs like heroin. By Devlin Barrett Reporting from Washington The Justice ...

The U.S. administration reclassified state-licensed or FDA approved marijuana products from a Schedule I to a Schedule III drug. This reclassification does not immediately change marijuana's legal ...

The Trump administration on Thursday announced that it was loosening restrictions on marijuana to boost medical research, days after President Donald Trump appeared to express frustration with the ...